[What do we konw about the Zika virus?]

Area of Science:

• Virology
• Epidemiology
• Public Health

Background:

• Zika virus (ZIKV), an RNA virus from the Flaviviridae family, was first identified in 1947.
• Sporadic human infections were reported until 2007, with a recent rapid spread in the Americas causing significant public health concern.
• The World Health Organization has issued warnings due to the increasing incidence of microcephaly in infants born to mothers infected during pregnancy.

Purpose of the Study:

• To highlight the epidemiological significance of Zika virus (ZIKV).
• To inform healthcare professionals about the transmission, diagnosis, treatment, and consequences of ZIKV infection.
• To emphasize the need for current knowledge regarding ZIKV for all medical specialties.

Main Methods:

• Review of existing literature on Zika virus (ZIKV) epidemiology and clinical manifestations.
• Analysis of transmission routes including blood, sexual contact, vertical transmission, and breastfeeding.
• Discussion of current diagnostic limitations and symptomatic treatment approaches.

Main Results:

• Zika virus (ZIKV) is spreading rapidly, particularly in the Americas, posing a serious epidemiological challenge.
• Key consequences of ZIKV infection include microcephaly in newborns and Guillain-Barre syndrome in infected individuals.
• Current diagnostic tests may lack specificity, detecting other flaviviruses, but are available in Poland.

Conclusions:

• Zika virus (ZIKV) infection presents significant risks, notably microcephaly and Guillain-Barre syndrome.
• Effective prevention and management strategies require updated medical knowledge on ZIKV.
• Continuous medical education is essential for healthcare providers to address the ZIKV threat effectively.